Sugentech Inc (253840) - Total Assets
Based on the latest financial reports, Sugentech Inc (253840) holds total assets worth ₩98.21 Billion KRW (≈ $66.56 Million USD) as of December 2025. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. See Sugentech Inc shareholders equity for net asset value and shareholders' equity analysis.
Sugentech Inc - Total Assets Trend (2017–2025)
This chart illustrates how Sugentech Inc's total assets have evolved over time, based on quarterly financial data.
Sugentech Inc - Asset Composition Analysis
Current Asset Composition (December 2025)
Sugentech Inc's total assets of ₩98.21 Billion consist of 56.9% current assets and 43.1% non-current assets.
| Asset Category | Amount (KRW) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | ₩0.00 | 20.2% |
| Accounts Receivable | ₩1.82 Billion | 1.9% |
| Inventory | ₩6.99 Billion | 7.1% |
| Property, Plant & Equipment | ₩0.00 | 0.0% |
| Intangible Assets | ₩741.62 Million | 0.8% |
| Goodwill | ₩0.00 | 0.0% |
Asset Composition Trend (2017–2025)
This chart illustrates how Sugentech Inc's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. For live market cap, price, and company overview, see 253840 market cap.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Sugentech Inc's current assets represent 56.9% of total assets in 2025, an increase from 41.4% in 2017.
- Cash Position: Cash and equivalents constituted 20.2% of total assets in 2025, up from 10.8% in 2017.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 0.0% of total assets, unchanged from 0.0% in 2017.
- Asset Diversification: The largest asset category is inventory at 7.1% of total assets.
Sugentech Inc Competitors by Total Assets
Key competitors of Sugentech Inc based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Demant A/S
CO:DEMANT
|
Denmark | Dkr39.07 Billion |
|
Double Medical Technology Inc
SHE:002901
|
China | CN¥4.55 Billion |
|
Beijing Wandong Medical Technology Co Ltd
SHG:600055
|
China | CN¥5.70 Billion |
|
Sinocare Inc
SHE:300298
|
China | CN¥6.25 Billion |
|
MODULIGHT OY EO 1
F:78W
|
Germany | €49.14 Million |
|
Diagnostic Medical Systems SA
PA:ALDMS
|
France | €57.17 Million |
|
Theradiag SA
PA:ALTHE
|
France | €11.55 Million |
|
Nova EYE Medical Ltd
AU:EYE
|
Australia | AU$23.67 Million |
Sugentech Inc - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 10.65 | 8.24 | 10.85 |
| Quick Ratio | 9.32 | 7.46 | 8.82 |
| Cash Ratio | 0.00 | 1.36 | 0.00 |
| Working Capital | ₩50.64 Billion | ₩56.37 Billion | ₩50.27 Billion |
Sugentech Inc - Advanced Valuation Insights
This section examines the relationship between Sugentech Inc's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 0.92 |
| Latest Market Cap to Assets Ratio | 0.00 |
| Asset Growth Rate (YoY) | -8.8% |
| Total Assets | ₩98.21 Billion |
| Market Capitalization | $57.82 Million USD |
Valuation Analysis
Below Book Valuation: The market values Sugentech Inc's assets below their book value (0.00x), which may indicate investor concerns about asset quality or future growth.
Significant Asset Reduction: Sugentech Inc's assets decreased by 8.8% over the past year, potentially indicating divestiture, restructuring, or challenging business conditions.
Annual Total Assets for Sugentech Inc (2017–2025)
The table below shows the annual total assets of Sugentech Inc from 2017 to 2025.
| Year | Total Assets | Change |
|---|---|---|
| 2025-12-31 | ₩98.21 Billion ≈ $66.56 Million |
-8.76% |
| 2024-12-31 | ₩107.64 Billion ≈ $72.95 Million |
-19.18% |
| 2023-12-31 | ₩133.19 Billion ≈ $90.26 Million |
-23.15% |
| 2022-12-31 | ₩173.30 Billion ≈ $117.44 Million |
+11.40% |
| 2021-12-31 | ₩155.56 Billion ≈ $105.42 Million |
+114.70% |
| 2020-12-31 | ₩72.46 Billion ≈ $49.10 Million |
+59.52% |
| 2019-12-31 | ₩45.42 Billion ≈ $30.78 Million |
+86.36% |
| 2018-12-31 | ₩24.37 Billion ≈ $16.52 Million |
+33.35% |
| 2017-12-31 | ₩18.28 Billion ≈ $12.39 Million |
-- |
About Sugentech Inc
Sugentech Inc. develops and sells in-vitro diagnostic systems and products based on biotechnology, information technology, and nanotechnology in South Korea and internationally. The company offers lab tests, including systems and test items; and COVID-19 tests. It also provides point of care testing analyzers and test items for testing of influenza A/B, antibody test, COVID-19 and flu, SARS-CoV-2… Read more